Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trialsResearch in context

Summary: Background: Whether there is a subset of patients with heart failure with preserved ejection fraction (HFpEF) that benefit from spironolactone therapy is unclear. We applied a machine learning approach to identify responders and non-responders to spironolactone among patients with HFpEF in...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Karl-Patrik Kresoja, Matthias Unterhuber, Rolf Wachter, Karl-Philipp Rommel, Christian Besler, Sanjiv Shah, Holger Thiele, Frank Edelmann, Philipp Lurz
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2023-10-01
Цуврал:	EBioMedicine
Нөхцлүүд:	Machine learning Heart failure with preserved ejection fraction Spironolactone
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2352396423003614
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!